BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02315326-completion@plaintrial.com
DTSTAMP:20261111T032446Z
DTSTART;VALUE=DATE:20260128
SUMMARY:Bruton's Tyrosine Kinase (BTK) Inhibitor\, Ibrutinib\, in Patients 
 With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous Syste
 m Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous Syst
 em Lymphoma (SCNSL) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02315326
URL:https://plaintrial.com/trial/NCT02315326
END:VEVENT
END:VCALENDAR